iifl-logo-icon 1

Plethico Pharmaceuticals Ltd Profit & Loss Statement

9.05
(-4.74%)
Jun 13, 2016|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 Mar( In .Cr)Dec-2012Dec-2011

Revenue

475.06

412

yoy growth (%)

15.3

Raw materials

-403.73

-258.43

As % of sales

84.98

62.72

Employee costs

-28.91

-35.39

As % of sales

6.08

8.59

Other costs

-50.31

-78.46

As % of sales (Other Cost)

10.59

19.04

Operating profit

-7.9

39.71

OPM

-1.66

9.63

Depreciation

-8.3

-8.23

Interest expense

-52.31

-78.52

Other income

38.14

82.61

Profit before tax

-30.37

35.55

Taxes

-0.84

-10.19

Tax rate

2.76

-28.67

Minorities and other

0

0

Adj. profit

-31.21

25.36

Exceptional items

23.32

-63

Net profit

-7.89

-37.63

yoy growth (%)

-79.03

NPM

-1.66

-9.13

Plethico Pharmaceuticals Ltd : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp